For more information visit: http://www.spponline.org/2010-2FallProgram.pdf
You can also contact us on: carol.burrows@cls.ab.ca
The 2010 SPP Fall Symposium will be held at the beautiful Rimrock Hotel in Banff, Alberta in conjunction with the Banff Pathology Review Course, which is run in alternate years by the University of Calgary or the University of Alberta (Edmonton). The 2010 Banff Pathology Review Course (Sept 2-4) will be run by the Department of Pathology & Laboratory Medicine, University of Calgary. Since 2010 marks the 10th anniversary for this popular topical CME course, we decided to do something different and hold this Course and the SPP Fall meeting back-to-back with the last half day shared between the two meetings. The topic for the Banff Pathology Review Course will be lymph node pathology (the first two days will be mostly adult) and the topic for the last half-day of the Banff Pathology Review Course (the morning of Sept 4) will be pediatric lymph node pathology and this will be a shared session with the SPP Symposium.
Synopsis:
The 2010 Fall SPP Symposium will provide a comprehensive update on pediatric lymph node pathology. Specific topics to be included are the new 2008 World Health Organization Lymphoma Classification Scheme (including newly recognized pediatric lymphoma entities), Hodgkin Lymphoma and its differential diagnosis, pediatric non-Hodgkin lymphomas, EBV-associated lymphoproliferative disorders, pediatric reactive lymphoproliferative disorders, and pediatric histiocytic/dendritic cell processes. Four world-class speakers have agreed to take part in the Symposium: Drs. Elaine S Jaffe, Ron Jaffe, Sherrie L Perkins and Lawrence M Weiss.
Needs Assessment:
Pediatric pathologists regularly need to update their knowledge related to pediatric lymph node pathology, which includes the following broad entities: Non-Hodgkin Lymphoma, Hodgkin Lymphoma, EBV-Associated Lymphoproliferative Disorders, Reactive Lymphoproliferative Lesions, and Histiocytic Processes. An update at this time is critical as a new World Health Organization classification scheme was announced in 2008 which recognizes several new pediatric lymphoma entities. Critical knowledge has evolved in all of the above-mentioned lymphoid entities. Our slate of world class speakers will address classification systems, clinical features, morphologic diagnosis, and the roles of immunohistochemistry and ancillary testing (molecular, cytogenetics, etc.) in the diagnosis and reporting of these lesions. The Symposium has been specifically designed to provide a comprehensive overview of the above-mentioned entities (see titles of talks and specific objectives for each speaker below) and to provide "one stop shopping" CME for the practicing pediatric pathologist's lymph node pathology needs.